glp-1 without diabetes Taking GLP‑1 in 2026: What Real People Notice After 3, 6 and 12 Months GLP-1 receptor agonism: a transformative

In its first registrational Phase 3 obesity trial (TRIUMPH-1), average weight loss reached 28.3% at 80 weeks and up to 30.3% at 104 weeks in a select extension cohort

The new monthly cadence replaces Hims previous 6-month upfront pricing, so you can start without committing to a big upfront payment

We recognize that every patients journey is unique, and the effectiveness of GLP-1 medications can vary

The point is not to be anti-medication

GLP-1 receptors (GLP1R), which are found in pancreatic beta cells as well as other cell types, receive the GLP-1 signal, triggering the release of insulin

The GLP-1 landscape is evolving quickly